Skip to content

13F-HR filed by Carlyle Group Inc.

Carlyle Group Inc. filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-05, with 30 holding rows worth $3,352,222,730.

Accession
0000898432-23-000256
Filed
2023-05-05
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A combination report, 31 entries on the cover page, a total value of $3,352,222,730 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,352,222,730 with VALUE read as dollars as filed, 13F file number 028-15025. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QUIDELORTHO CORP COM219798105Stock12,460,183$1,110,077,703dollars as filed
ZOOMINFO TECHNOLOGIES INC COMMON STOCK98980F104Stock36,662,469$905,929,609dollars as filed
MKS INC. COM55306N104Stock8,482,732$751,739,711dollars as filed
VITRU LTDG9440D103COM6,246,471$142,169,680dollars as filed
GDS HLDGS LTD SPONSORED ADS36165L108ADR4,072,624$75,995,171dollars as filed
VAXCYTE INC COM92243G108Stock1,923,158$72,079,962dollars as filed
GETTY IMAGES HOLDINGS INC374275105CL A COM11,902,817$60,585,339dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS2,457,500$49,346,600dollars as filed
HILLEVAX INC43157M102COM1,838,486$30,096,016dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK2,960,231$22,882,586dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK2,935,106$20,868,604dollars as filed
JASPER THERAPEUTICS INC471871103COM8,761,891$15,771,404dollars as filed
INVITATION HOMES INC COM46187W107REIT477,500$14,912,325dollars as filed
RENEO PHARMACEUTICALS INC75974E103COM2,073,957$12,236,346dollars as filed
ADICET BIO INC007002108COM2,115,385$12,163,464dollars as filed
LIFE STORAGE INC53223X107COM86,000$11,273,740dollars as filed
CUBESMART COM229663109REIT220,500$10,191,510dollars as filed
SEACOR MARINE HLDGS INC COM78413P101Stock1,314,043$9,999,867dollars as filed
SPRUCE BIOSCIENCES INC85209E109COM2,896,518$6,401,305dollars as filed
SMART SH GLOBAL LTD83193E102ADS4,810,209$5,339,331dollars as filed
NUCANA PLC67022C106ADR3,333,333$3,200,333dollars as filed
PARATEK PHARMACEUTICALS INC699374302Equity1,041,131$2,623,650dollars as filed
SOLENO THERAPEUTICS INC834203309COM1,201,506$2,535,178dollars as filed
EFFECTOR THERAPEUTICS INC28202V108COM4,822,114$1,687,740dollars as filed
CYMABAY THERAPEUTICS INC23257D103COM131,036$1,143,944dollars as filed
META DATA LIMITED68276W400SPONSORED ADS314,400$329,303dollars as filed
SIENTRA INC82621J204COMMON167,358$256,058dollars as filed
EXICURE INC30205M200COM NEW281,636$242,207dollars as filed
MOLECULAR TEMPLATES INC608550109COM200,000$75,020dollars as filed
AEGLEA BIOTHERAPEUTICS INC00773J103COM240,500$69,024dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000898432-23-000256this filing2023-05-05acceptance time not in the bulk data set